Acadia Pharmaceuticals Inc (ACAD) insider trading.
In Q3 2026, insiders at Acadia Pharmaceuticals Inc reported 8 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $1.0M.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -36,699
- Insiders
- 2
- Last filed
- 2026-08-07
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Schneyer Mark C. | Officer · EVP, CHIEF FINANCIAL OFFICER | 5 | 0 | 3 |
| Thompson Elizabeth H.Z. | Officer · EVP, Head of Research & Dev | 3 | 0 | 2 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Schneyer Mark C. | S (D) | 5,000 | $29 | 77,120 | Form 4 |
| 2026-08-06 | Schneyer Mark C. | S (D) | 9,292 | $29.34 | 67,828 | Form 4 |
| 2026-08-06 | Schneyer Mark C. | M (A) | 14,292 | $17.84 | 82,120 | Form 4 |
| 2026-08-05 | Schneyer Mark C. | M (A) | 5,849 | $17.84 | 73,677 | Form 4 |
| 2026-08-05 | Schneyer Mark C. | S (D) | 5,849 | $29 | 67,828 | Form 4 |
| 2026-07-30 | Thompson Elizabeth H.Z. | S (D) | 50 | $26.17 | 18,994 | Form 4 |
| 2026-07-30 | Thompson Elizabeth H.Z. | S (D) | 16,508 | $26.13 | 19,044 | Form 4 |
| 2026-07-29 | Thompson Elizabeth H.Z. | M (A) | 32,272 | — | 35,552 | Form 4 |
Transaction codes in this quarter
Get ACAD insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1070494&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ACAD company page · Acadia Pharmaceuticals Inc on SEC.gov
Questions
Are insiders buying or selling Acadia Pharmaceuticals Inc (ACAD)?
In Q3 2026, insiders at Acadia Pharmaceuticals Inc reported 8 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $1.0M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Acadia Pharmaceuticals Inc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/acad.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.